Strategies for the design of novel thrombolytic and antithrombolytic agents
- 30 June 1992
- journal article
- review article
- Published by Elsevier in Trends in Cardiovascular Medicine
- Vol. 2 (3) , 84-89
- https://doi.org/10.1016/1050-1738(92)90011-g
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Platelet-targeted fibrinolysis enhances clot lysis and inhibits platelet aggregation.Circulation, 1991
- A single base-pair deletion in the protein C gene causing recurrent thromboembolismThrombosis Research, 1991
- Inhibition of thrombus formation by activated recombinant protein C in a primate model of arterial thrombosis.Circulation, 1990
- Characterization of Thrombin- and Plasmin-Resistant Mutants of Recombinant Human Single Chain Urokinase–Type Plasminogen Activator1The Journal of Biochemistry, 1990
- Biochemical properties of conjugates of urokinase‐type plasminogen activator with a monoclonal antibody specific for cross‐linked fibrinEuropean Journal of Biochemistry, 1989
- Thrombolytic and pharmacokinetic properties of conjugates of urokinase-type plasminogen activator with a monoclonal antibody specific for crosslinked fibrinFibrinolysis, 1989
- Innovative Approaches to Plasminogen Activator TherapyScience, 1989
- Inactivation of single-chain urokinase (pro-urokinase) by thrombin and thrombin-like enzymes: relevance of the findings to the interpretation of fibrin-binding experimentsBlood, 1987
- Antibody-Directed Urokinase: A Specific Fibrinolytic AgentScience, 1985
- A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex.Journal of Clinical Investigation, 1985